BIRC5
MOLECULAR TARGETbaculoviral IAP repeat containing 5
BIRC5 (baculoviral IAP repeat containing 5) is targeted by 4 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting BIRC5
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | benziodarone | 2.40 | 10 |
| 2 | sepantronium bromide | 2.30 | 9 |
| 3 | Buthionine Sulfoximine | 1.39 | 3 |
| 4 | Vitamin K 3 | 1.39 | 3 |
About BIRC5 as a Drug Target
BIRC5 (baculoviral IAP repeat containing 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 4 compounds with documented BIRC5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
BIRC5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.